PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31349003-14 2019 The levels of MMP-2 and MMP-9/tissue inhibitors of metalloproteinases (TIMP)-1 ratio (MMP-9/ TIMP-1), also decreased significantly and the decline could be associated with TOS. tos 172-175 matrix metallopeptidase 9 Homo sapiens 24-29 31349003-14 2019 The levels of MMP-2 and MMP-9/tissue inhibitors of metalloproteinases (TIMP)-1 ratio (MMP-9/ TIMP-1), also decreased significantly and the decline could be associated with TOS. tos 172-175 matrix metallopeptidase 9 Homo sapiens 86-91 24398310-14 2014 In VATS and TOS groups, the serum VEGF and MMP-9 levels also initially increased and subsequently decreased. tos 12-15 matrix metallopeptidase 9 Homo sapiens 43-48 24398310-17 2014 CONCLUSIONS: Serum VEGF and MMP-9 remarkably increase in TOS group and VATS group. tos 57-60 matrix metallopeptidase 9 Homo sapiens 28-33 24398310-18 2014 Although the serum level of VEGF an MMP-9 in TOS group were higher than that in VATS group. tos 45-48 matrix metallopeptidase 9 Homo sapiens 36-41